HB 13012025–2026
bill
2025–2026 Regular Session · House of Representatives bill
HB 1301
An Act requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.
In committee Last action April 28, 2025: Referred to Health
Official bill page and text: palegis.us
Sponsors 21
- Prime sponsor
- Tarik Khan
- Cosponsors (20)
- Andre Carroll, Benjamin Sanchez, Bridget Kosierowski, Carol Hill-Evans, Chris Pielli, Danielle Friel Otten, G. Roni Green, Greg Scott, Johanny Cepeda-Freytiz, Jose Giral, Joseph Hohenstein, La'Tasha Mayes, Lisa Borowski, Liz Hanbidge, Malcolm Kenyatta, Mandy Steele, Mary Jo Daley, Nancy Guenst, Rick Krajewski, Steven Malagari
Status
In committee as of April 28, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.
Roll-call votes 0
No roll-call votes recorded for this measure.
Timeline 1
| Date | Chamber | Action |
|---|---|---|
| April 28, 2025 | House | Referred to Health |
Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.